Ronald M. Nordmann

Ronald M. Nordmann appears in our data through filings on PAR Pharmaceutical Companies, Inc. shares, published by SEC (Form 4). The record holds 18 filings, for trades running from 9 January 2006 to 28 September 2012.

Market trades split into 1 purchase (€26k) and 12 sales (€273k). The net balance comes to €247k on the selling side. Unlike grants, an open-market purchase is paid for by the insider, at the market price. The rest of the record consists of 2 share grants and 2 option exercises. Since January 2012: no purchases and 9 sales on the market.

Most recently, on 2 October 2012, the filings show a transaction worth €155k in PAR Pharmaceutical Companies, Inc. The latest purchase dates back some time: it was published 6,960 days ago, on 3 October 2007. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. Section 16 rules allow two business days to file each Form 4. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.